D-1813-2015 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- September 23, 2015
- Initiation Date
- September 10, 2015
- Termination Date
- February 13, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37,078 cartons
Product Description
ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.
Reason for Recall
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.
Distribution Pattern
Nationwide
Code Information
Lot #: 233169, Exp 02/16